Guangzhou Boji Medical and Biotechnological Co Ltd (300404) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.008x

Based on the latest financial reports, Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has a cash flow conversion efficiency ratio of -0.008x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.39 Million ≈ $-1.08 Million USD) by net assets (CN¥918.92 Million ≈ $134.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Guangzhou Boji Medical and Biotechnologi fund operations to measure how many days the company can operate on defensive assets alone.

Guangzhou Boji Medical and Biotechnological Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Guangzhou Boji Medical and Biotechnological Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangzhou Boji Medical and Biotechnological Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Boji Medical and Biotechnological Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nanjing Well Pharmaceutical Co Ltd SHG:603351	0.039x
Jilin University Zhengyuan Info Tech SHE:003029	-0.019x
Summit Hotel Properties Inc NYSE:INN	0.035x
Ozak Gayrimenkul Yatirim Ortakligi AS IS:OZKGY	0.000x
Raubex JSE:RBX	0.058x
Songz Automobile Air Conditioning Co Ltd SHE:002454	0.014x
Shenzhen Longli Technology Co Ltd Class A SHE:300752	0.018x
Ginkgo Bioworks Holdings NYSE:DNA	-0.105x

Annual Cash Flow Conversion Efficiency for Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Guangzhou Boji Medical and Biotechnologi.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.06 Billion ≈ $155.04 Million	CN¥87.01 Million ≈ $12.73 Million	0.082x	+207.18%
2024-12-31	CN¥1.00 Billion ≈ $146.59 Million	CN¥26.78 Million ≈ $3.92 Million	0.027x	-27.12%
2023-12-31	CN¥980.11 Million ≈ $143.42 Million	CN¥35.95 Million ≈ $5.26 Million	0.037x	+15.86%
2022-12-31	CN¥888.72 Million ≈ $130.05 Million	CN¥28.14 Million ≈ $4.12 Million	0.032x	-10.97%
2021-12-31	CN¥846.38 Million ≈ $123.85 Million	CN¥30.10 Million ≈ $4.40 Million	0.036x	-82.23%
2020-12-31	CN¥485.00 Million ≈ $70.97 Million	CN¥97.07 Million ≈ $14.20 Million	0.200x	+106199.25%
2019-12-31	CN¥456.08 Million ≈ $66.74 Million	CN¥85.87K ≈ $12.57K	0.000x	-99.71%
2018-12-31	CN¥423.71 Million ≈ $62.00 Million	CN¥27.06 Million ≈ $3.96 Million	0.064x	+0.92%
2017-12-31	CN¥414.35 Million ≈ $60.63 Million	CN¥26.22 Million ≈ $3.84 Million	0.063x	+179.45%
2016-12-31	CN¥429.84 Million ≈ $62.90 Million	CN¥-34.24 Million ≈ $-5.01 Million	-0.080x	-1889.41%
2015-12-31	CN¥432.68 Million ≈ $63.32 Million	CN¥1.93 Million ≈ $281.83K	0.004x	-96.21%
2014-12-31	CN¥218.48 Million ≈ $31.97 Million	CN¥25.69 Million ≈ $3.76 Million	0.118x	-44.43%
2013-12-31	CN¥205.52 Million ≈ $30.07 Million	CN¥43.48 Million ≈ $6.36 Million	0.212x	-12.94%
2012-12-31	CN¥170.36 Million ≈ $24.93 Million	CN¥41.40 Million ≈ $6.06 Million	0.243x	--

About Guangzhou Boji Medical and Biotechnological Co Ltd

SHE:300404 China Biotechnology

Market Cap

$489.40 Million

CN¥3.34 Billion CNY

Market Cap Rank

#12500 Global

#3683 in China

Share Price

CN¥8.67

Change (1 day)

+0.70%

52-Week Range

CN¥8.33 - CN¥13.15

All Time High

CN¥297.35